Resolution in Pittsburgh: DOJ Greenlights Highmark BCBS Deal

Matthew Skoufalos | | Radiology Business | Business Intelligence
Sparks are settling in the Steel City as the Antitrust Division of the U.S. Department of Justice (DOJ) cleared the way for Highmark Blue Cross and Blue Shield to proceed with its half-billion-dollar buy-up of the struggling West Penn Allegheny Health System (WPAHS). In a statementannouncing its decision, the DOJ ruled that the $475 million deal wouldn’t disincentivize competition from the failing health system “because WPAHS has strong incentives to increase its patient volume…[and] has previously tried to sponsor entry by national insurers and largely failed.” The move will commence without former Highmark CEO Kenneth R. Melani, who was shown the door last week after a highly publicized brawl with the estranged husband of his mistress.

Matthew Skoufalos

Related Content

Orano Med breaks ground on $265M thorium production site
Image-interpretation market scoreboard: Radiologists 72%, others 28%
Lantheus lands rights to budding radiopharmaceuticals for initial outlay of $35M
17 short-term strategies to address the national radiologist shortage
‘SR’ onboards another independent practice, its 1st in the Natural State
Analysis: Allied radiology professionals generate millions of dollars per year in indirect revenues alone

Around the web

Health Imaging
Nearly $800,000 settlement offered to family of man who died during MRI exam

The patient, who was being cared for in the ICU, was not accompanied or monitored by nursing staff during his exam, despite being sedated.

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.